|May 30 - 31, 2017||
Four Seasons Boston
200 Boylston Street
Boston, MA 02116
Starting at $1950
Boston CEO is a networking forum for industry CEOs and decision makers in the life sciences. Attendees gain insights from presentations and panels featuring CEOs from several of the world's leading biopharmaceutical companies. Industry leaders in venture capital and private equity also participate.
Speakers and co-hosts include: Paul Biondi, SVP, Head, BD, Bristol-Myers Squibb; Ron Cooper, President & CEO, Albireo Pharma; Robert Coughlin, President & CEO, Mass Bio; Deborah Dunsire, CEO, XTuit Pharmaceuticals; Michael Ehlers, EVP, R&D, Biogen; JC Gutierrez-Ramos, CEO, Synlogic Therapeutics; John Haurum, CEO, F-star Biotechnology; Mary Lynne Hedley, Co-Founder, President & COO, TESARO; William Heiden, CEO, AMAG Pharmaceuticals; Ed Kaye, CEO & CMO, Sarepta Therapeutics; Jonathan Lewis, CEO, Samus Therapeutics; Martin Mackay, EVP, Head, R&D, Alexion; John Maraganore, CEO, Alnylam; Geoffrey McDonough, President & CEO, Swedish Orphan Biovitrum; David Meek, CEO, IPSEN; Kia Motesharei, VP, Global Head of BD, Neurology & Immunology, EMD Serono; Francois Nader, Chairman, Acceleron Pharma; Paris Panayiotopoulos, former President & CEO, ARIAD; Adelene Perkins, Chairman & CEO, Infinity Pharmaceuticals; Steven Perrin, CEO & CSO, ALSTDI; Roger Pomerantz, President, CEO & Chairman, Seres Therapeutics; Chandra Ramanathan, VP & Head, East Cost Innovation Center, Bayer; Al Sandrock, CMO & EVP, Neurology Discovery & Development, Biogen; Cynthia Schwalm, EVP of Commercial Operations, North America, IPSEN; Bob Silverman, Head Externalized Drug Discovery Partnering, Roche; Paula Soteropoulos, CEO, Akcea Therapeutics; Henri Termeer, former CEO, Genzyme; Roger Tung, CEO, Concert Pharmaceuticals; Sue Washer, President & CEO, AGTC; Christoph Westphal, Co-Founder & Partner, Longwood Fund
"Every year I look forward to Boston CEO, the elite meeting for leaders in biotech. This top notch meeting features unrivaled networking and candid discussions on the most pressing topics facing the industry.” - Henri Termeer, former CEO, Genzyme
"The Boston CEO conference is an invaluable opportunity for CEOs to gather in a casual and off-the-record atmosphere and discuss the most pressing issue in the biotech space and beyond. I look forward to these conferences and fully support their mission to continue to grow Boston’s thriving biopharma community.” — John Maraganore, CEO, Alnylam
Please call reservations at the Four Seasons today to book your accommodations. Telephone: (617) 338-4400. Please mention the Boston Biotech Conference rate.
Premier Sponsors: (see all sponsors)